Cargando…
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition
[Image: see text] Osteoarthritis (OA) is the most common degenerative joint disease. In 1999, two members of the A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) family of metalloproteinases, ADAMTS4 and ADAMTS5, or aggrecanases, were identified as the enzymes responsible for...
Autores principales: | Cuffaro, Doretta, Ciccone, Lidia, Rossello, Armando, Nuti, Elisa, Santamaria, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620172/ https://www.ncbi.nlm.nih.gov/pubmed/36250680 http://dx.doi.org/10.1021/acs.jmedchem.2c01177 |
Ejemplares similares
-
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
por: Santamaria, Salvatore, et al.
Publicado: (2021) -
Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)
por: Santamaria, Salvatore, et al.
Publicado: (2015) -
Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives
por: Di Leo, Riccardo, et al.
Publicado: (2023) -
An overview of carbohydrate-based carbonic anhydrase inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2020) -
New isoxazolidinyl-based N-alkylethanolamines as new activators of human brain carbonic anhydrases
por: Cuffaro, Doretta, et al.
Publicado: (2023)